Searchable abstracts of presentations at key conferences in endocrinology

ea0026p62 | Endocrine tumours and neoplasia | ECE2011

Injection systems for long-acting somatostatin analogs: a comparative assessment of preparation times and nurses' perceptions

Adelman D T , Burgess A , Davies P R

Introduction: The two major long-acting somatostatin analogues (SSA) available on the European market for the treatment of neuroendocrine tumours and acromegaly are Somatuline Autogel (SA) and Sandostatin LAR (LAR). The aim of this study was to gain nurses’ insights on the use and ease of administration of SSA devices, including Somatuline Autogel new device (SA-ND), in Europe and the US.Methods/design: Seventy-seven qualified nurses with ≥3 S...

ea0036P81 | (1) | BSPED2014

A case report of TRβ mutation leading to raised T4 levels presenting with abnormal body habitus

Tomlinson N D , Banerjee I , Chatterjee K , Smith T D , Mukherjee A

Introduction: We present a 5-year-old girl with thyroid hormone resistance, subsequently discovered to be heterozygous for TRβ mutation. This case highlights the necessity to investigate, in detail, all children with persistently high thyroxin with normal TSH levels in order to aid future management and the necessity to follow them up.Case report: SD was born at term by normal delivery weighing 3.34 kg (50th centile). She was referred at 6 months of...

ea0026p346 | Obesity | ECE2011

AM251, a CB1 receptor antagonist, increases GLUT4 expression in adipocytes

Furuya D T , Poletto A C , Freitas H S , Machado U F

Evidences have suggested that the endocannabinoid system is overactive in obesity, resulting in enhanced endocannabinoid levels in both circulation and visceral adipose tissue. The cannabinoid CB1 receptor is expressed in the adipose tissue besides the brain. Few studies in vitro suggest that CB1 activation increases glucose uptake in adipocytes. The objective of the present study was to investigate the CB1 receptor modulation on glucose transporter GLUT4 expression, which is ...

ea0026p358 | Steroid metabolism | ECE2011

Chronic effect of 17β estradiol on GLUT4 expression in 3T3-L1 adipocytes

Campello R S , Poletto A C , Furuya D T , Mori R C T , Machado U F

Introduction: Insulin resistance results from a combination of genetic and environmental factors and it may be considered the primary cause of the development of metabolic disorders, such as type 2 diabetes mellitus. It is characterized by a reduced ability of insulin sensitivity tissues to respond to normal levels of the hormone. In these tissues, glucose transport stimulated by insulin occurs through the glucose transporter 4 and alterations in its expression are related to ...

ea0024oc2.8 | Oral Communications 2 (Brief Communications) | BSPED2010

Radio-iodine therapy for autoimmune hyperthyroidism. A two centre, retrospective evaluation of practice and outcomes

Wnuk W , Balan K K , Cheetham T D , Acerini C L

Radio-iodine (I131) (RI) is regarded as an effective therapy for patients with autoimmune hyperthyroidism (AH). Treatment protocols and outcomes are well defined in adult endocrinology practice but not for children and adolescents where RI is now considered a safe therapy option after relapse following anti-thyroid drugs (ATD). We retrospectively evaluated the use of RI in 36 patients (6M) with AH from 2 regional units located in the North and East of England. Data ...

ea0026p359 | Nuclear receptors | ECE2011

Oleic and linoleic fatty acids reduce the SLC2A4 gene expression: the involvement of the NFkappaB and HIF-1a transcriptional factors

Poletto A C , Furuya D T , dos Santos R A , Anhe G F , Silva A D , Campello R S , Machado U F

Introduction: High circulating levels of some but not all unsaturated fatty acids (UFAs) can be related with reduced insulin sensitivity and glucose uptake in skeletal muscle. The real mechanisms by which UFAs impair the insulin sensitivity need to be clarified; nevertheless the UFA’s effects in the regulation of activity and/or expression of some transcriptional factors such as, nuclear factor κB (NFκB), hypoxia inducible factor-1a (HIF-1a), peroxisome prolifer...

ea0014p545 | (1) | ECE2007

Is there an endocrine explanation for persistent neuropsychological disabilities long after traumatic brain injury (TBI)?

Yollin Edwige , Kozlowski Odile , Soudan Benoît , D’Herbomez Michèle , Fontaine Pierre , Rousseaux Marc , Cortet-Rudelli Christine

The aims of this study were to determine the prevalence of pituitary dysfunction in patients keeping neuropsychological disabilities long after TBI (at least 1 year), to research predictive factors and to evaluate consequences of endocrine abnormalities on metabolism and quality of life in these patients.We studied 50 patients (42 men, mean age 36, range 20–59 years, mean BMI 25, range 17–42 kg/m2) who had survived severe (n=3...

ea0081ep858 | Reproductive and Developmental Endocrinology | ECE2022

Perceptions and experiences of women with polycystic ovary syndrome- a systematic review

Mun Lau Gar , Elghobashy Mirna , Thanki Mansi , Ibegbulam Shirley , Gleeson Helena , Robinson Lynne , Latthe Pallavi , Gillett Caroline D. T , Arlt Wiebke , Lindenmeyer Antje , Kempegowda Punith , SEva Working Group PCOS

Introduction: With a global prevalence of around 10%, polycystic ovary syndrome (PCOS) is a common endocrine condition affecting women. Despite its prevalence, limited evidence exists around the condition and its impact on patients. Qualitative research provides insights into symptoms and experiences faced by women with PCOS that can affect management and compliance.Aim: A systematic review was undertaken to evaluate the current literature on ...

ea0081ep909 | Reproductive and Developmental Endocrinology | ECE2022

PCOS pearls - findings from the qualitative study assessing the lived experience of people with polycystic ovary syndrome

Elghobashy Mirna , Lau Gar Mun , Busby Maureen , Stacke Kristine , Latthe Pallavi , Gleeson Helena , Robinson Lynne , Arlt Wiebke , Lindenmeyer Antje , Gillett Caroline D. T , Kempegowda Punith , Seva Working Group PCOS

Introduction: Existing educational resources for polycystic ovary syndrome (PCOS) have limited inclusion of patient perspectives. We invited women with PCOS to share their lived experiences to understand their perception and opinion on the current standard of care.Methodology: Women with PCOS aged 18-60 years were invited to complete an online survey in April and May 2021. The survey had open questions focused on their lived experiences with PCOS. Partic...